Document is current
Any future updates will be listed below
-
Authors
Fulcher, James M. https://orcid.org/0000-0001-9033-3623
Markillie, Lye Meng https://orcid.org/0000-0001-8275-4882
Mitchell, Hugh D. https://orcid.org/0000-0003-0143-8461
Williams, Sarah M.
Engbrecht, Kristin M.
Degnan, David J. https://orcid.org/0000-0001-5737-7173
Bramer, Lisa M. https://orcid.org/0000-0002-8384-1926
Moore, Ronald J. https://orcid.org/0000-0003-2806-2855
Chrisler, William B.
Cantlon-Bruce, Joshua
Bagnoli, Johannes W.
Qian, Wei-Jun https://orcid.org/0000-0002-5393-2827
Seth, Anjali
Paša-Tolić, Ljiljana https://orcid.org/0000-0001-9853-5457
Zhu, Ying https://orcid.org/0000-0002-5416-0566
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (UH3CA256959)
- License Information
-
More Information
Article History
Received: 16 May 2024
Accepted: 1 November 2024
First Online: 5 December 2024
Competing interests
: J.C.B., J.W.B, and A.S. are employees of Scienion/Cellenion. Y.Z. is an employee of Genentech Inc. and shareholder of Roche Group. Battelle Memorial Institute has submitted a U.S. patent application for the design of nanoSPLITS devices and the associated operation methods (Application number: 17/954,834, filed 09/28/2022; Inventors: Y.Z., J.M.F., L.M.M., and L.P.T.; Status of application: Pending). Other authors declare no other competing interests.
